Aducanumab: FDA approved new drug against Alzheimer’s disease after two decades
Dr. Juni Banerjee, PhD; Neucrad Health Desk, June 26, 2021 Alzheimer’s disease (AD) affects nearly 50 million people all over...
FDA approval
Carmat Total Artificial Heart (C-TAH) approval by the European Commission: Current Medical Trends
Dr. Juni Banerjee, Neucrad Health Desk, Jan 31, 2021 https://youtu.be/3gdEUnz0zJA Neucrad Health Hub, a digital health platform, a brainchild of a NRI Neuroscientist, Biswarup Ghosh,...
Kesimpta®(Ofatumumab): Targeted B-cell Therapy for Relapsing forms of Multiple Sclerosis
Dr. Juni Banerjee, PhD; Neucrad Health Desk, September 4, 2020 The Novartis drug Kesimpta® has been recently approved by FDA...
The First ever FDA approved CAR-T cell therapy for the treatment of Mantle Cell Lymphoma (MCL)
Dr. Shuvomoy Banerjee, PhD. from Neucrad Health Desk; July 31,2020 ‘TecartusTM’ has recently become the first ever approved CAR-T cell...
Fabiflu: India’s First Approved Oral Antiviral Drug to combat Covid-19 pandemic
Neucrad Health June 23, 2020 The latest addition to the coronavirus treatment strategy is the launch of an oral antiviral...
FDA Approves First And Only Innovative “Gene Therapy” For Children With Spinal Muscular Atrophy (SMA)
By Gaurav Bedse, Ph.D, Research Instructor, Vanderbilt University Medical Center, Nashville, TN May 26, 2019 The U.S. Food and Drug...
